Son, Tran Kim
Toan, Ngo Hoang
Thang, Nguyen
Le Trong Tuong, Huynh
Tien, Hoang Anh
Thuy, Nguyen Hai
Van Minh, Huynh
Valensi, Paul
Article History
Received: 3 February 2022
Accepted: 7 April 2022
First Online: 14 May 2022
Declarations
:
: The study protocol was approved by our institution’s ethics committee, and informed consent for the procedure was obtained from each participant.
: Not applicable.
: PV discloses the following potential conflicts of interest: lectures for Abbott, AstraZeneca, Bayer, Eli Lilly, Hikma Pharmaceuticals, Merck Sharp & Dohme, Novo Nordisk, Novartis, Pfizer, Sanofi; research grants from Abbott, Bristol-Myers Squibb–AstraZeneca, Novo Nordisk; participation in expert committees for AstraZeneca, Boehringer Ingelheim, Novo Nordisk, Daiichi Sankyo, Sanofi, Servier. The other authors declare they have no conflict of interest.